In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice.

about

Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.Asking the Right Questions With Animal Models: Methionine- and Choline-Deficient Model in Predicting Adverse Drug Reactions in Human NASH.

P2860

Q39183375-375A3F46-088B-4009-80B0-F30F03FF3D30 Q47584564-DF2E8D4E-3978-4CC3-97D6-14509E62BA41

P2860

In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice.

Item

http://www.wikidata.org/entity/Q38814148

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

In vivo cytochrome P450 activi ...... lcoholic steatohepatitis mice.

@en

type

Item

label

In vivo cytochrome P450 activi ...... lcoholic steatohepatitis mice.

@en

prefLabel

In vivo cytochrome P450 activi ...... lcoholic steatohepatitis mice.

@en

P1476

In vivo cytochrome P450 activi ...... lcoholic steatohepatitis mice.

@en

P2093

Anika L Dzierlenga

http://www.w3.org/2001/XMLSchema#string

John Bear

http://www.w3.org/2001/XMLSchema#string

John D Clarke

http://www.w3.org/2001/XMLSchema#string

Michael J Goedken

http://www.w3.org/2001/XMLSchema#string

Nathan J Cherrington

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease

Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame

Non-alcoholic fatty liver: another feature of the metabolicsyndrome?

Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH)

Synergistic interaction between genetics and disease on pravastatin disposition

Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet

From NAFLD to NASH to cirrhosis-new insights into disease mechanisms.

NAFLD, NASH and liver cancer.

Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis.

Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis.

P31

scholarly article

P356

10.1002/JBT.21840

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hui Li

P577

2016-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27712037

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

5426479

http://www.w3.org/2001/XMLSchema#string

In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice.

about

P2860

P2860

In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932